Autodesk (NASDAQ:ADSK) Rises on UBS $400 Target, Rate Cut Optimism
Autodesk Inc. (NASDAQ:ADSK) shares increased in premarket trading on November 26, 2025, after UBS set a price target of $400. This target suggests a potential upside of 35.86% from its reference trading price of $294.43.
In premarket trading, Autodesk's stock price increased by 1.58%, or $4.58, trading between $287.11 and $297.67. This positive movement coincided with a broader upward trend in U.S. stock futures, which recorded a three-day winning streak. The rally occurred during a holiday-shortened week.
Investor sentiment is buoyed by anticipation of a potential December interest rate cut. Dovish guidance from the central bank supports this outlook. The 10-year Treasury bond yield stood at 4.01%, and the two-year bond at 3.46%. The CME Group's FedWatch tool indicates an 84.9% probability of a rate reduction next month.
Autodesk's trading volume on the NASDAQ exchange reached 2,327,384 shares, indicating strong investor interest. The company, known for its design and engineering software, holds a market capitalization of approximately $62.99 billion. Over the past year, ADSK has traded between a high of $329.09 and a low of $232.67.
For more information on Autodesk Inc., you can explore its history, mission and vision, financial health, and investor profile.
Autodesk, Inc. (ADSK) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.